ESC Premium Access

Balancing residual inflammatory, lipid, and thrombotic risk in coronary artery disease

Congress Presentation

About the speaker

Professor Peter Libby

Brigham and Women's Hospital, Boston (United States of America)
31 presentations

3 more presentations in this session

Innovative strategies for lipid lowering treatment: PCSK9 inhibition

Speaker: Professor F. Mach (Geneva, CH)


Anti-inflammatory therapy : interleukin-1 beta inhibition to prevent cardiovascular events

Speaker: Doctor P. Ridker (Boston, US)


Prolonged P2Y12 inhibition or Factor Xa inhibition in patients after an acute coronary syndrome

Speaker: Doctor T. Cuisset (Marseille, FR)


Access the full session

Innovative strategies for secondary prevention

Speakers: Professor P. Libby, Professor F. Mach, Doctor P. Ridker, Doctor T. Cuisset

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Related content

Open Access

SGLT-2 Inhibitors in Heart Failure: Where are we now and where are we heading?

27 August 2021

Open Access

GUIDE-HF - Panel discussion.

27 August 2021

Open Access

Panel Discussion: The case for combination therapy: The way forward in intensive LDL-c management?

27 August 2021

ESC 365 is supported by

logo Novo Nordisk